AIM: To examine the expression of pancreatic duodenal homeobox-1 (PDX-1) transcription factor in human colorectal cancer. METHODS: RT-PCR, Western blotting, and immuno-histochemistry were performed to determine the expression pattern of transcription factor PDX-1 in primary colorectal tumor, hepatic metastasis, and benign colon tissue from a single patient. RESULTS: The highest PDX-1 transcription levels were detected in the metastasis material. Lower levels of PDX-1 were found to be present in the primary tumor, while normal colon tissue failed to express detectable levels of PDX-1. Western blot data revealed a PDX-1 expression pattern identical to that of mRNA expression. Immunohistochemistry confirmed high metastasis PDX-1 expression, lower levels in the primary tumor, and the presence of only traces of PDX-1 in normal colon tissue. CONCLUSION: These data argue for further evaluation of PDX-1 as a biomarker for colorectal cancer.
AIM: To examine the expression of pancreatic duodenal homeobox-1 (PDX-1) transcription factor in humancolorectal cancer. METHODS: RT-PCR, Western blotting, and immuno-histochemistry were performed to determine the expression pattern of transcription factor PDX-1 in primary colorectal tumor, hepatic metastasis, and benign colon tissue from a single patient. RESULTS: The highest PDX-1 transcription levels were detected in the metastasis material. Lower levels of PDX-1 were found to be present in the primary tumor, while normal colon tissue failed to express detectable levels of PDX-1. Western blot data revealed a PDX-1 expression pattern identical to that of mRNA expression. Immunohistochemistry confirmed high metastasis PDX-1 expression, lower levels in the primary tumor, and the presence of only traces of PDX-1 in normal colon tissue. CONCLUSION: These data argue for further evaluation of PDX-1 as a biomarker for colorectal cancer.
Authors: Krzysztof Okoń; Monika Zazula; Zbigniew Rudzki; Bolesław Papla; Czesław Osuch; Jerzy Stachura Journal: Pol J Pathol Date: 2004 Impact factor: 1.072
Authors: G M Beattie; P Itkin-Ansari; V Cirulli; G Leibowitz; A D Lopez; S Bossie; M I Mally; F Levine; A Hayek Journal: Diabetes Date: 1999-05 Impact factor: 9.461
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer Journal: Gastroenterology Date: 2008-02-08 Impact factor: 22.682
Authors: Mark A Feanny; Shawn P Fagan; Nikiforos Ballian; Shi-He Liu; Zhijun Li; Xiaoping Wang; William Fisher; F Charles Brunicardi; Narasimhaswamy S Belaguli Journal: J Surg Res Date: 2007-06-20 Impact factor: 2.192
Authors: Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi Journal: World J Surg Date: 2011-08 Impact factor: 3.352
Authors: Shi-He Liu; Sanjeet Patel; Marie-Claude Gingras; John Nemunaitis; Guisheng Zhou; Changyi Chen; Min Li; William Fisher; Richard Gibbs; F Charles Brunicardi Journal: Cancer Date: 2010-09-30 Impact factor: 6.860
Authors: Justin F Creeden; Khaled Alganem; Ali S Imami; Nicholas D Henkel; F Charles Brunicardi; Shi-He Liu; Rammohan Shukla; Tushar Tomar; Faris Naji; Robert E McCullumsmith Journal: Int J Mol Sci Date: 2020-11-21 Impact factor: 5.923
Authors: Shi-He Liu; Guisheng Zhou; Juehua Yu; James Wu; John Nemunaitis; Neil Senzer; David Dawson; Min Li; William E Fisher; F Charles Brunicardi Journal: Genes (Basel) Date: 2013-07-19 Impact factor: 4.096